Chemical Compound

Decarbamylcefuroxime

CAS Registry Number 97170-19-9
Back to search Request a Quote
Decarbamylcefuroxime chemical structure
Primary Record

Decarbamylcefuroxime

In stock
8,408 g
Purity
98.2 %
CAS
97170-19-9

Compound Identifiers & Properties

CAS
97170-19-9
PubChem CID
11280470
SMILES
CO/N=C(\C1=CC=CO1)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CO)C(=O)O
Canonical SMILES
CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CO)CS[C@H]12)c1ccco1

Names & Synonyms

  • Decarbamylcefuroxime
  • Descarbamoyl Cefuroxime
  • RefChem:69699
  • Cefuroxime EP Impurity F
  • P7563XP7TW
  • 3-hydroxy methyl Cefuroxime
  • Cefuroxime sodium impurity F
  • UNII-P7563XP7TW
  • Cefuroxime Sodium EP Impurity F
  • 97170-19-9
  • Cefuroxime sodium impurity F [EP]
  • SCHEMBL29709125
  • OUSLHGWWWMRAIG-FBCAJUAOSA-N
  • DTXSID101101426
  • EINECS 260-086-2
  • ZINC13552105
  • ACN-045440
  • CS-O-06086
  • CID11280470
  • J296.625E
  • CEFUROXIME SODIUM IMPURITY F [EP IMPURITY]
  • CEFUROXIME SODIUM IMPURITY F (EP IMPURITY)
  • 56271-94-4
  • CEFUROXIME SODIUM EP IMPURITY F (REFERENCE GRADE)
  • (6R,7R)-7-(((2E)-2-(2-Furanyl)-2-(methoxyimino)acetyl)amino)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[[(2E)-2-(2-Furanyl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2E)-2-(2-furanyl)-2-(methoxyimino)acetyl)amino)-3-(hydroxymethyl)-8-oxo-, (6R,7R)-
  • (6R,7R)-7-((Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-((2-FURANYL(METHOXYIMINO)ACETYL)AMINO)-3-(HYDROXYMETHYL)-8-OXO-, (6R-(6.ALPHA.,7.BETA.(E)))-
  • 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-furanyl(methoxyimino)acetyl)amino)-3-(hydroxymethyl)-8-oxo-, (6R-(6alpha,7beta(E)))-
  • 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2E)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-, (6R,7R)-
  • (6R)-7alpha-[[2-Furanyl(methoxyimino)acetyl]amino]-3-hydroxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-3-hydroxymethyl-7-[(Z)-2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acid
  • (6r,7r)-3-hydroxymethyl-7-[z-2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylic acid
  • (6R,7R)-7-((E)-2-(furan-2-yl)-2-(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[[(2Z)-2-(2-Furanyl)-2-(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
  • (6R,7R)-7-[[(E)-(furan-2-yl)(methoxyimino)acetyl]amino]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[2-(furan-2-yl)-2-(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[Z-2-(Fur-2-yl)-2-methoxyiminoacetamido]-3-hydroxymethyl ceph-3-em-4-carboxylic acid
  • (6R,7R)-7-[Z-2-(fur-2-yl)-2-methoxyiminoacetamido]-3-hydroxymethyl-ceph-3-em-4-carboxylic acid
  • (6r,7r)-7-[z-2-(fur-2-yl)-2-methoxyiminoacetamido]-3-hydroxymethylceph-3-em-4-carboxylic acid
  • (6R,7R)-7-[Z-2-(fur-2-yl)-2-methoxyiminoacetamido]-3-hydroxymethylceph-3-em-4carboxylic acid
  • (6R,7R)-7-[Z-2-(fur-2-yl)-2-methoxyiminoacetamido]-3hydroxymethylceph-3-em-4-carboxylic acid
  • (6R,7R)-7-[Z-2-(fur-2-yl)-2-methyoxyiminoacetamido]-3-hydroxymethylceph-3-em-4-carboxylic acid
  • [6R-[6alpha,7beta(Z)]]-7-[2-furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid